WASATCH ADVISORS INC 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 12:40 pm Sale |
2024-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 3,627,308 3.800% |
-1,112,837 (-23.48%) |
Filing |
| 2023-01-10 2:38 pm Sale |
2023-01-10 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 4,740,145 5.010% |
-3,495,623 (-42.44%) |
Filing |
| 2022-02-10 1:38 pm Sale |
2022-02-10 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 8,235,768 10.100% |
-83,444 (-1.00%) |
Filing |
| 2021-12-02 11:31 am Purchase |
2021-12-02 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 8,319,212 10.200% |
1,985,312 (+31.34%) |
Filing |
| 2021-02-09 3:23 pm Purchase |
2021-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 6,333,900 7.900% |
6,333,900 (New Position) |
Filing |